Company · CIK 0001743881 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
BridgeBio Pharma, Inc. · BBIO
Insider activity reported against this company. All insider holders · Files at: EIDX. On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 17, 2026 SForm 4 → | Sep 21, 6:21 pm EDT | Neil KumarChief Executive Officer, Director | 10,000 | $69.08 | $690,847 | 495,686 | −1.98% | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.
Filed by this entity as an insider elsewhere — common stock
No reported common-stock activity in this period.
Filed by this entity as an insider elsewhere — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.